Abstract

It is well known that induction of hepatocyte senescence could inhibit the development of hepatocellular carcinoma (HCC). Until now, it is still unclear how the degree of liver injury dictates hepatocyte senescence and carcinogenesis. In this study, we investigated whether the severity of injury determines cell fate decisions between hepatocyte senescence and carcinogenesis. After testing of different degrees of liver injury, we found that hepatocyte senescence is strongly induced in the setting of severe acute liver injury. Longer-term, moderate liver injury, on the contrary did not result into hepatocyte senescence, but led to a significant incidence of HCC instead. In addition, carcinogenesis was significantly reduced by the induction of severe acute injury after chronic moderate liver injury. Meanwhile, immune surveillance, especially the activations of macrophages, was activated after re-induction of senescence by severe acute liver injury. We conclude that severe acute liver injury leads to hepatocyte senescence along with activating immune surveillance and a low incidence of HCC, whereas chronic moderate injury allows hepatocytes to proliferate rather than to enter into senescence, and correlates with a high incidence of HCC. This study improves our understanding in hepatocyte cell fate decisions and suggests a potential clinical strategy to induce senescence to treat HCC.

Details

Title
The extent of liver injury determines hepatocyte fate toward senescence or cancer
Author
Wang, Chao 1 ; Wen-Jian, Chen 2 ; Ying-Fu, Wu 2 ; You, Pu 3 ; Shang-Yong, Zheng 4 ; Chang-Cheng, Liu 5 ; Dao Xiang 6 ; Min-Jun, Wang 2 ; Yong-Chao, Cai 5 ; Qing-Hui, Zhao 5 ; Borjigin, Uyunbilig 7 ; Liu, Wei 5 ; Wu-Jun, Xiong 8 ; Wangensteen, Kirk J 9 ; Wang, Xin 10 ; Zhong-Min, Liu 5 ; Zhi-Ying He 1   VIAFID ORCID Logo 

 Department of Cell Biology, Center for Stem Cell and Medicine, Second Military Medical University, Shanghai, China; Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China 
 Department of Cell Biology, Center for Stem Cell and Medicine, Second Military Medical University, Shanghai, China 
 School of Medicine, Tongji University, Shanghai, China 
 School of Medicine, Yunnan University, Kunming, Yunnan, China 
 Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China 
 Naval Medicine Research Institute, Second Military Medical University, Shanghai, China 
 The Key Laboratory of National Education Ministry for Mammalian Reproductive Biology and Biotechnology, Inner Mongolia University, Huhhot, China 
 Department of Hepatology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China 
 Department of Medicine, Division of Gastroenterology, University of Pennsylvania, Philadelphia, PA, USA 
10  The Key Laboratory of National Education Ministry for Mammalian Reproductive Biology and Biotechnology, Inner Mongolia University, Huhhot, China; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA; Hepatoscience Incorporation, Sunnyvale, CA, USA 
Pages
1-14
Publication year
2018
Publication date
May 2018
Publisher
Springer Nature B.V.
e-ISSN
20414889
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2054147526
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.